Biovail Accuses Elan, Fournier Of Misleading USPTO

By Liz McKenzie (November 10, 2009, 4:41 PM EST) -- Biovail Corp. has fired back in a lawsuit over its generic formulation of cholesterol treatment TriCor, alleging that the patents for TriCor owned by Elan Pharma International Ltd. and Fournier Laboratories Ireland Ltd. are invalid....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!